Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Cell & Gene Therapy

Grit Bio Closes $60 Million Round for Tumor-Infiltrating Lymphocyte Oncology Drugs
Neurophth to Begin Australian Trial of Gene Therapy for Visual Impairment
CARsgen and Moderna to Test Dual Claudin18.2 Cancer Therapy Combo
CytoMed Signs MOU with CNK Therapeutics for Gene Grafting Technology in CAR Therapies
Gracell Raises $100 Million in Private Placement for Trials of CAR-T Candidates
ChinaBio Event
September 20-21 | Shanghai
September 25-26 | Digital
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China